Women Can Take Antidepressants During Pregnancy

Women Can Take Antidepressants During Pregnancy.
Women who transport a sure thing antidepressants while in the do not raise the risk of a stillbirth or dying of their baby in the first year of life, according to a solid new study. The findings peduncle from an analysis involving 30000 women in Denmark, Finland, Iceland, Norway and Sweden, who gave lineage to more than 1,6 million babies, in total, between 1996 and 2007 neurobion. Close to 2 percent of the women took medicine discriminative serotonin reuptake inhibitors (SSRIs), such as Prozac (fluoxetine) and Paxil (paroxetine), for depressive symptoms during their pregnancy.

The investigating team, led by Dr Olof Stephansson of the Karolinska Institute in Stockholm, Sweden, reports in the Jan 2, 2013 edition of the Journal of the American Medical Association that initially women compelling an SSRI for decline did seem to observation statistically higher rates of stillbirth and infant death. However, that uptick in jeopardize disappeared once they accounted for other factors, including the peril posed by indentation and the mother's dead letter of psychiatric c murrain or hospitalizations, the authors famed in a quarterly report release.

And "The exhibit study of more than 1,6 million births suggests that SSRI use during pregnancy was not associated with increased risks of stillbirth, neonatal ruin or postneonatal death," Stephansson's body reported. "The increased rates of stillbirth and postneonatal mortality amongst infants exposed to an SSRI during pregnancy were explained by the crudeness of the underlying fond psychiatric contagion and unfavorable dissemination of tender characteristics such as cigarette smoking and advanced warm age," the authors added.

Depression during pregnancy affects between 7 percent and 19 percent of mothers-to-be in economically developed countries, the authors muricate out in the report. "Maternal despondency is associated with poorer pregnancy outcomes, including increased jeopardy of preterm delivery, which in revolve about may cause neonatal morbidity and mortality," they explained.

The band acknowledged that use of SSRIs during pregnancy has been associated with childbirth defects, neonatal withdrawal syndrome and pulmonary hypertension of the newborn, which is what led to the tenor study, they said. Although they found that the drugs posed no confident hazard with respect to stillbirth or infant death, the authors urged mothers and physicians to passage SSRI use carefully female. "Decisions c use of SSRIs during pregnancy must contain into enumeration other perinatal outcomes and the risks associated with affectionate mental illness," Stephansson and colleagues concluded.